Accession Number: | 0001209191-19-000519 |
Date: | 2018-12-31 |
Issuer: | AMARIN CORP PLC\UK (AMRN) |
Original Submission Date: |
KETCHUM STEVEN B
C/O AMARIN PHARMA, INC.
1430 ROUTE 206
BEDMINSTER, NJ 07921
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2018-12-31 | M | 2,604 | a | $1.40 | 343,901 f3 | direct | ||
ORDINARY SHARES | 2018-12-31 | M | 4,167 | a | $2.50 | 348,068 f3 | direct | ||
ORDINARY SHARES | 2018-12-31 | M | 3,750 | a | $2.50 | 351,818 f3 | direct | ||
ORDINARY SHARES | 2018-12-31 | M | 3,750 | a | $2.50 | 355,568 f3 | direct | ||
ORDINARY SHARES | 2018-12-31 | M | 2,770 | a | $2.95 | 358,338 f3 | direct | ||
ORDINARY SHARES | 2018-12-31 | S | 17,041 | d | $13.51 | 341,297 f3 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.4 | 2018-12-31 | deemed execution date | M | 2,604 (d) | 2026-01-31 | ordinary shares 2,604 | $1.40 | 33,854 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.5 | 2018-12-31 | deemed execution date | M | 4,167 (d) | 2025-07-06 | ordinary shares 4,167 | $2.50 | 24,998 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.5 | 2018-12-31 | deemed execution date | M | 3,750 (d) | 2025-07-06 | ordinary shares 3,750 | $2.50 | 22,500 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.5 | 2018-12-31 | deemed execution date | M | 3,750 (d) | 2025-07-06 | ordinary shares 3,750 | $2.50 | 52,938 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.95 | 2018-12-31 | deemed execution date | M | 2,770 (d) | 2027-01-31 | ordinary shares 2,770 | $2.95 | 69,770 | direct |
ID | footnote |
---|---|
f1 | the option exercises and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan previously adopted by the reporting person. |
f2 | the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share. |
f3 | please see the section titled "remarks" below for additional information. |
f4 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $13.22 to $13.84, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f5 | on february 1, 2016, the reporting person was granted an option to purchase 125,000 ordinary shares under the amarin corporation plc 2011 stock incentive plan (the "plan"). the shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on february 29, 2016. |
f6 | on july 6, 2015, the reporting person was granted an option to purchase 200,000 ordinary shares under the plan. the shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on july 31, 2015. |
f7 | on july 6, 2015, the reporting person was granted an option to purchase 180,000 ordinary shares under the plan. the vesting of the shares is subject to certain performance milestone that was previously achieved. the shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on july 31, 2015. |
f8 | on february 1, 2017, the reporting person was granted an option to purchase 133,000 ordinary shares under the plan. the shares subject to this option shall vest and become exercisable in 48 equal monthly installments on the last day of each month that began on february 28, 2017. |